A blockbuster breast cancer niche has Roche and Sanofi in the lead

A blockbuster breast cancer niche has Roche and Sanofi in the lead

Special Reports The 10 most-anticipated drug launches of 2020

Special Reports The 10 most-anticipated drug launches of 2020

Roche SMA therapy granted speedy FDA review; decision by May 2020

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!  Dive Brief: The Food and Drug Administration will give Roche's experimental therapy for spinal muscular atrophy a speedy review and will decide on approval within six months, the Swiss pharma​ said Monday. If approved, Roche's risdiplam would be the third SMA therapy … Συνεχίστε να διαβάζετε Roche SMA therapy granted speedy FDA review; decision by May 2020.

5 questions ESMO cancer drug data might answer

5 questions ESMO cancer drug data might answer

Roche’s Tecentriq, on an EU hot streak, bags 2 new lung cancer approvals

Roche's Tecentriq, on an EU hot streak, bags 2 new lung cancer approvals